Hoffmann-La Roche Inc.

Martine Vriesema-van Vugt

Paul Parren

Erhard Kopetzki

Jan Van De Winkel

Olaf Mundigl

Ralf Schumacher

Klaus-Peter Kuenkele

Yvo Graus

Frank Rebers

Antibodies against insulin like growth factor I receptor (IGF-IR), methods for their production, pharmaceutical compositions containing the antibodies, and uses for the antibodies are disclosed. Antibodies against IGF-IR are implicated in antitumor therapy.

Antibody selection method against IGF-IR

Antibodies against insulin like growth factor I receptor (IGF-IR), methods for their production, pharmaceutical compositions containing said antibodies, and uses for such antibodies are disclosed. Antibodies against IGF-IR are implicated in antitumor therapy.

Antibodies against insulin-like growth factor I receptor and uses thereof

Antibodies which bind to IGF-IR and inhibit the binding of IGF-I and IGF-II to IGF-IR are characterized. These antibodies are implicated in anti-tumor therapy.

Antibodies against insulin-like growth factor 1 receptor and uses thereof

Growing community of inventors

Houten, Netherlands

Martine Vriesema-van Vugt